60 articles, transcripts, and reports
AbbVie (NYSE: ABBV) reported fourth quarter 2022 earnings results today. Worldwide net revenues increased 1.6% year-over-year to $15.1 billion. Net earnings attributable to AbbVie Inc.…
AbbVie (NYSE: ABBV) Q3 2022 Earnings Conference
AbbVie (NYSE: ABBV) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Elizabeth Shea — Vice President, Head of Investor Relations Richard Gonzalez — Chairman of the Board,…
Biopharmaceutical firm AbbVie Inc. (NYSE: ABBV) is currently at a crucial juncture as it strives to overcome the threat from generic competitors to its flagship…
AbbVie (NYSE: ABBV) Q2 2022 Earnings Conference
AbbVie (NYSE: ABBV) Q1 2022 Earnings Conference
AbbVie (NYSE: ABBV) Q1 2022 earnings call dated Apr. 29, 2022 Corporate Participants: Elizabeth Shea — Vice President, Head of Investor Relations Richard A. Gonzalez — Chairman of the…
AbbVie (NYSE: ABBV) Q4 2021 earnings call dated Feb. 02, 2022 Corporate Participants: Elizabeth Shea — Vice President, Investor Relations Richard A. Gonzalez — Chairman of the Board and…
AbbVie (NYSE: ABBV) today reported its fourth-quarter financial results for the period ended December 31, 2021. Net revenues increased 7.4% to $14.8 billion. Net income…
The AlphaStreet research report provides actionable data and insights into AbbVie’s fundamentals, the industry, and competition. The report is meant as a resource for investors…
